APA (7th ed.) Citation

A, P., R, G., A, B., A, T., R, I., P, Z., . . . M, S. (2026). Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Cancer treatment reviews, 149, 103178. https://doi.org/10.1016/j.ctrv.2026.103178

Chicago Style (17th ed.) Citation

A, Pretta, et al. "Distinct Outcome Patterns According to RAS and BRAF Status in MSI-H/dMMR MCRC Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis." Cancer Treatment Reviews 149 (2026): 103178. https://doi.org/10.1016/j.ctrv.2026.103178.

MLA (9th ed.) Citation

A, Pretta, et al. "Distinct Outcome Patterns According to RAS and BRAF Status in MSI-H/dMMR MCRC Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis." Cancer Treatment Reviews, vol. 149, 2026, p. 103178, https://doi.org/10.1016/j.ctrv.2026.103178.